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IL‐lβ, IL‐6, TNF―α, EGF, TGF‐βl, β2-MG, タンパク量の測定





































site)とした。Exp.siteの24時間後のIL‐lβ量 (0。88±0.1l pgノμ )は移動開
始直後のExp.siteのIL‐lβ量 (0。38±0.07 pg/μg,p=0,0077)ならびに24時
間後のConto siteのIL‐lβ量 (0.32±0.08 pgノμ ,p=0.0034)に比べて統計学
的に有意に上昇した (図3a)。これらの結果はこれまでに報告されたものと一
致する 16)。Expo stteの24時間後のTNF‐α量 (1。13±0.06 pg′μ )は移動開始
直後のExp.siteのTNF―α量 (0。43±0.14 pgノμ ,p=0.006),168時間後の
Exp.siteのTNF―α量 (0.29±0.03 pgノμ ,p=0.0133)ならびに24時間後の
Ant.siteのTNF―α量 (0.41±0。14 pgノμg,p=0.0193)に比べて有意 上昇し





昇した (図3c).Expo siteの24時間後のEGF量(0。82±0。1l pg′μg)は移動
開始直後のExpo siteのEGF量(0.18±0.13 pgノμ ,p=0.oo76)ならびに24
時間後のAnt.siteのEGF量(0.30±.12 pg′μg,p=0.0471)に比べて有意に
上昇した (図3d).Exp.stteの24時間のTGF‐βl量(0.89±0。18 pgノμg)は
移動開始直後のExpo siteのTGF―βl量 (0。43±0.14 pgノμ ,p=0.0198)なら
びに24時間後のAnto steのTGF‐βl量(0.21±0.06 pgノμ ,p=0.o233)に比





















































































































GrOwth Factor,and Transforming GrOwth Factor¨βl levels are





Matsumo o Dental Conege, shi可hi,
Key words:IL‐lβ,TNFα,IL…6,EGF,TGF‐βl,GCF,orthodontic tooth
movement.
Bone remodehng is a complex process regulated by several inediators。
Recent work has revealed that cytokines and growth factors have
signincant e■bcts On bone cen metabolism.HOwever,little information is
ava■able concerning the productibn of cytokines during orthodontic tooth
movement in human sutteCtS,and there is no non¨mvasive model for
deterIIlining the productibn of cytokhes.Therefore,the purpose of this
study was to ident量シ an  quant」レ the VariOus cytokines in human
15
glng市al crevicular iuid(GCF),and tO investigate the changes in the士
levels during orthodOntic tooth movement.Twelve patients(mean age,
14。4 years)were used as sutteCtSo An upper canine ofeach patient ha宙ng
one treatment for distal lnovements served as the experilnental tooth,
whereas the contralateraland antagonistic canines were used as controls.
The GCF around the experllnental and the twO cOntrol teeth was taken
iom each suttectimmediately before act市ation,and at l,24,and 168 hr
ater the initiation oftoOth nlovemento Cytokine levels were deternlined by
ELISAs.The concentrations Of interleukin cL)‐lβ, tuΠLOr n Crosis
factor‐(χ,IL‐6,epidermal growth factOr,and transforming gro就h factor‐
βl Were signincantly higher in the experilnental group than in the
controls at 24 hr after the the experiΠl nt was initiated.A■the cytOkines
remained at basehne levels throughout the experilnent fOr the bⅣO cOn rol
groups.In contrast to cytokine alteration,the amount of total protem in
the GCF exhibited a gradual increase,but no signincant direrence was
observed bebⅣeen the control and expe五mental groupso Since an cytokines
in GCF play an important role in the bone remodeling prOcesses ih l燿tro,
the present results hdicate that the changes llll cytokines in GCF are
associated with orthOdontic tooth lllovement。
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